OVERVIEW

Amid the COVID-19 pandemic, the Global Human Microbiome Market is expected to grow at a CAGR of 8.1% during the forecast period 2021-2026. The increasing focus on the advancement of human microbiome therapy is driving market growth. It has also established itself as a viable target for drug growth. During the forecast period, the increasing number of market player alliances is expected to provide a diverse range of growth opportunities for market players. The report will also account for COVID-19 as a key market contributor.

TABLE OF CONTENT

• 1 Global Human Microbiome Market - Overview
  • 1.1 Study Objectives
  • 1.2 Market Definition
  • 1.3 Study Scope
    • 1.3.1 Markets Covered
    • 1.3.2 Geographic Scope
• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions
• 3 Global Human Microbiome Market – Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography
• 4 Global Human Microbiome Market – Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis
• 5 Global Human Microbiome Market – Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis – Top 10 companies
• 6 Global Human Microbiome Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
      • 6.2.1.1 Growing awareness about human microbiome therapy
      • 6.2.1.2 Increasing incidence of lifestyle-related diseases
      • 6.2.1.3 Growing geriatric population
    • 6.2.2 Restraints
      • 6.2.2.1 Lack of comprehensive research
    • 6.2.3 Opportunities
      • 6.2.3.1 Investigational New Drug (IND) requirements for fecal microbiota
    • 6.2.4 Challenges
      • 6.2.4.1 Stringent government regulations
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes
• 7 Global Human Microbiome Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Product Life Cycle
  • 7.3 Supplier and distributor analysis (Market share and product dealing strategies)
• 8 Global Human Microbiome Market – By Product (Market Size – & million/billion)
  • 8.1 Probiotics
  • 8.2 Foods
  • 8.3 Prebiotics
  • 8.4 Medical Foods
  • 8.5 Diagnostic Devices
  • 8.6 Drugs
  • 8.7 Other
• 9 Global Human Microbiome Market - By Technology
  • 9.1 Cell Culture Technology
  • 9.2 High-Throughput Technology
  • 9.3 Omics Technology
  • 9.4 Computational Tools
• 10 Global Human Microbiome Market - By Disease
  • 10.1 Obesity
  • 10.2 Diabetes
  • 10.3 Autoimmune Disorder
  • 10.4 Cancer
  • 10.5 Gastrointestinal Disorders
  • 10.6 Central Nervous System Disorders
  • 10.7 Other Diseases
• 11 Global Human Microbiome Market - By Application
  • 11.1 Therapeutics
  • 11.2 Diagnostics
• 12 Global Human Microbiome Market – By Geography (Market Size – & million/billion)
  • 12.1 Introduction
  • 12.2 North America
    • 12.2.1 US
    • 12.2.2 Canada
    • 12.2.3 Mexico
  • 12.3 Europe
    • 12.3.1 U.K
    • 12.3.2 Germany
    • 12.3.3 Italy
    • 12.3.4 France
    • 12.3.5 Spain
    • 12.3.6 Rest of Europe
  • 12.4 Asia-Pacific
    • 12.4.1 China
    • 12.4.2 Japan
    • 12.4.3 India
    • 12.4.4 South Korea
    • 12.4.5 Rest of APAC
  • 12.5 Rest of the World
    • 12.5.1 South America
    • 12.5.2 Middle East
    • 12.5.3 Africa
• 13 Global Human Microbiome Market – Entropy
  • 13.1 New product launches
  • 13.2 M&A's, collaborations, JVs and partnerships
• 14 Global Human Microbiome Market Company Profile (Key Players)
  • 14.1 Market Share, Company Revenue, Products, M&A, Developments
  • 14.2 Yakult Honsha Co. Ltd
  • 14.3 Synthetic Biologics Inc.
  • 14.4 Enterome Bioscience
  • 14.5 Merck & Co., Inc.
  • 14.6 DuPont
  • 14.7 Metabiomics Corporation
  • 14.8 Seres Therapeutics
  • 14.9 Second Genome
  • 14.10 Microbiome Therapeutics, LLC
  • 14.11Osel, Inc.
  • 14.12 Company 11 & more

"* Private Company Financials would be provided on our best efforts"

• 15 Global Human Microbiome Market - Appendix
  • 15.1 Sources
  • 15.2 Abbreviations